Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc. financial statements

Allarity Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 320K10-K
Net income−USD 11.23M10-K
Cash and equivalentsUSD 14.69M10-Q
Total debtUSD 1.4MEODHD

Allarity Therapeutics, Inc. financials on 6ix · Allarity Therapeutics, Inc. on 6ix